Literature DB >> 25066559

Agreement between public register and adjudication committee outcome in a cardiovascular randomized clinical trial.

Erik Kjøller1, Jørgen Hilden2, Per Winkel3, Søren Galatius4, Niels Jørgen Frandsen5, Gorm B Jensen6, Jørgen Fischer Hansen7, Jens Kastrup8, Christian M Jespersen9, Per Hildebrandt10, Hans Jørn Kolmos11, Christian Gluud12.   

Abstract

UNLABELLED: The objective of this study is to describe the agreement between randomized trial outcome assessment by committee and outcomes entirely identified through public registers.
METHODS: In the CLARICOR trial, 4,372 patients with stable coronary heart disease received a short course of clarithromycin versus placebo and were followed up for 2.6 years. The pertinent hospital records and death certificates had originally been evaluated by the adjudication committee using common definitions of outcomes mapped into a 6-category list. We now mechanically converted the International Classification of Diseases-coded diagnoses of the public registries into the same categories. After cross-tabulation of the committee diagnoses with National Patient Register diagnoses and Register of Causes of Death, we calculate agreement and compare the estimated intervention effects of the 2 data sets.
RESULTS: With public register data, the protocol-specified categories were slightly more frequent. Overall agreement was 74% for hospital discharges and 60% for cause of death, but the intervention effect, expressed as a hazard ratio, stayed within 4% of the value originally obtained with the adjudication committee (P ≥ .35).
CONCLUSIONS: Our results show a modest agreement between formal adjudication and outcomes deducible from public registers. However, the estimated intervention effect did not differ noticeably between the 2 data sources. If studies on a wide range of public registers confirm these findings, register outcomes may be considered as a replacement for adjudication committees.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25066559     DOI: 10.1016/j.ahj.2013.12.032

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

1.  Validation of Administrative Claims to Ascertain Outcomes in Pivotal Trials of Transcatheter Aortic Valve Replacement.

Authors:  Neel M Butala; Jordan B Strom; Kamil F Faridi; Dhruv S Kazi; Yuansong Zhao; J Matthew Brennan; Jeffrey J Popma; Changyu Shen; Robert W Yeh
Journal:  JACC Cardiovasc Interv       Date:  2020-07-15       Impact factor: 11.195

2.  The association between depressive mood and ischemic heart disease: a twin study.

Authors:  M K Wium-Andersen; I K Wium-Andersen; M B Jørgensen; M McGue; T S H Jørgensen; K Christensen; M Osler
Journal:  Acta Psychiatr Scand       Date:  2019-08-01       Impact factor: 6.392

3.  Use of administrative data to increase the practicality of clinical trials: Insights from the Women's Health Initiative.

Authors:  Garnet L Anderson; Carolyn J Burns; Joseph Larsen; Pamela A Shaw
Journal:  Clin Trials       Date:  2016-06-30       Impact factor: 2.486

4.  10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.

Authors:  Axel C Carlsson; Toralph Ruge; Erik Kjøller; Jørgen Hilden; Hans Jørn Kolmos; Ahmad Sajadieh; Jens Kastrup; Gorm Boje Jensen; Anders Larsson; Christoph Nowak; Janus Christian Jakobsen; Per Winkel; Christian Gluud; Johan Ärnlöv
Journal:  J Am Heart Assoc       Date:  2018-04-23       Impact factor: 5.501

5.  Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III).

Authors:  Martin Schultz; Line Jee Hartmann Rasmussen; Malene H Andersen; Jakob S Stefansson; Alexander C Falkentoft; Morten Alstrup; Andreas Sandø; Sarah L K Holle; Jeppe Meyer; Peter B S Törnkvist; Thomas Høi-Hansen; Erik Kjøller; Birgitte Nybo Jensen; Morten Lind; Lisbet Ravn; Thomas Kallemose; Theis Lange; Lars Køber; Lars Simon Rasmussen; Jesper Eugen-Olsen; Kasper Karmark Iversen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-08-28       Impact factor: 2.953

6.  Predictors for major cardiovascular outcomes in stable ischaemic heart disease (PREMAC): statistical analysis plan for data originating from the CLARICOR (clarithromycin for patients with stable coronary heart disease) trial.

Authors:  Per Winkel; Janus Christian Jakobsen; Jørgen Hilden; Theis Lange; Gorm Boje Jensen; Erik Kjøller; Ahmad Sajadieh; Jens Kastrup; Hans Jørn Kolmos; Anders Larsson; Johan Ärnlöv; Christian Gluud
Journal:  Diagn Progn Res       Date:  2017-03-29

7.  Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy.

Authors:  Martin Schultz; Line J H Rasmussen; Thomas Høi-Hansen; Erik Kjøller; Birgitte N Jensen; Morten N Lind; Lisbet Ravn; Thomas Kallemose; Theis Lange; Lars Køber; Lars S Rasmussen; Jesper Eugen-Olsen; Kasper K Iversen
Journal:  Dis Markers       Date:  2019-05-19       Impact factor: 3.434

8.  Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease.

Authors:  Jakob Schroder; Janus Christian Jakobsen; Per Winkel; Jørgen Hilden; Gorm Boje Jensen; Ahmad Sajadieh; Anders Larsson; Johan Ärnlöv; Marina Harutyunyan; Julia S Johansen; Erik Kjøller; Christian Gluud; Jens Kastrup
Journal:  J Am Heart Assoc       Date:  2020-03-02       Impact factor: 5.501

9.  Prognostic value of 12 novel cardiological biomarkers in stable coronary artery disease. A 10-year follow-up of the placebo group of the Copenhagen CLARICOR trial.

Authors:  Per Winkel; Janus Christian Jakobsen; Jørgen Hilden; Gorm Boje Jensen; Erik Kjøller; Ahmad Sajadieh; Jens Kastrup; Hans Jørn Kolmos; Kasper Karmark Iversen; Mette Bjerre; Anders Larsson; Johan Ärnlöv; Christian Gluud
Journal:  BMJ Open       Date:  2020-08-20       Impact factor: 2.692

10.  Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course.

Authors:  Per Winkel; Janus Christian Jakobsen; Jørgen Hilden; Gorm Jensen; Erik Kjøller; Ahmad Sajadieh; Jens Kastrup; Hans Jørn Kolmos; Anders Larsson; Johan Ärnlöv; Christian Gluud
Journal:  Open Heart       Date:  2018-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.